PP129 – Safety evaluation of cancer immunotherapy in a lung-on-chip model: the therapeutic FOLR1 targeting T Cell Bispecific antibody

Giulia Raggi, Switzerland

Source: ERS Lung Science Conference 2021
Number: 61

E-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Giulia Raggi, Switzerland. PP129 – Safety evaluation of cancer immunotherapy in a lung-on-chip model: the therapeutic FOLR1 targeting T Cell Bispecific antibody. ERS Lung Science Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: